Benjamin Edwards Inc Astrazeneca PLC Transaction History
Benjamin Edwards Inc
- $6.91 Billion
- Q1 2025
A detailed history of Benjamin Edwards Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Benjamin Edwards Inc holds 54,992 shares of AZN stock, worth $4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
54,992
Previous 56,075
1.93%
Holding current value
$4 Million
Previous $3.67 Million
9.99%
% of portfolio
0.06%
Previous 0.05%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,430Shares Held
507MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.15 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.95 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.59 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.31 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.27 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $225B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...